- Lack of Human Data – Current research relies primarily on animal models (e.g., Gunn rats), which may not fully replicate the complexities of kernicterus in human brains.
- First-of-its-Kind Opportunity – Blue’s donation, along with Jos’s, represents the first human samples available for long-term kernicterus research, enabling direct study of bilirubin-induced brain damage.
- Verification of Findings – Human tissue is critical to confirm or challenge assumptions from animal studies, ensuring the accuracy of research conclusions.
- Understanding Long-Term Impact – Existing studies focus on infant cases; research on adult brains with kernicterus will provide insight into lifelong neurodegenerative effects.
- Targeting the Affected Cells – Studying human brain tissue allows researchers to pinpoint which brain cells are most vulnerable, leading to a better understanding of kernicterus pathology.
- Potential for Neuroprotection & Treatment – Identifying how kernicterus affects brain cells over time could pave the way for future therapies, interventions, and protective strategies.
- Exposing the Reality – Denial within the medical community has led to underreporting, misclassification, and dismissal of kernicterus cases. Human brain studies provide undeniable proof of its existence and impact.
- Building Infrastructure for Future Research – Just as organ donation required systems to make it accessible, human brain research on kernicterus needs sustainable infrastructure to ensure continued study.
- Driving Policy & Prevention – Concrete scientific evidence from human brains can push for stronger medical guidelines, improved newborn jaundice management, and policy changes to prevent future cases.
- Families Deserve Answers – Those affected by kernicterus have never had a clear explanation of its full neurological effects. Research can provide clarity, validation, and hope for those living with kernicterus and their families.
